The epidemiology of candidemia in two United States cities: results of a population-based active surveillance.
about
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance PPhase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemiaRisk factors for fatal candidemia caused by Candida albicans and non-albicans Candida speciesHow Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future DirectionsPharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsNational surveillance of fungemia in Denmark (2004 to 2009)Epidemiology of invasive candidiasis: a persistent public health problemCandida-induced prosthetic joint infection. A literature review including 72 cases and a case report.Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011.Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.A comparison of two sources of data on fungaemia in two hospitals.Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.Pharmacological advances in the treatment of invasive candidiasis.Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies.One year prospective survey of Candida bloodstream infections in Scotland.Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.Intestinal resident yeast Candida glabrata requires Cyb2p-mediated lactate assimilation to adapt in mouse intestineSeminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.Emerging issues in antibiotic resistance in blood-borne infections.Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.Antimicrobial and antioxidant activity of kaempferol rhamnoside derivatives from Bryophyllum pinnatum.Prophylactic antifungal therapy in the intensive care unit.Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity.Use of denaturing high-performance liquid chromatography for rapid detection and identification of seven Candida species.Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.Candidemia in Finland, 1995-1999.Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in SpainRelationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009Economic considerations of antifungal prophylaxis in patients undergoing surgical proceduresThe Ess1 prolyl isomerase is required for growth and morphogenetic switching in Candida albicans.
P2860
Q24535844-DEF43F50-9609-435E-B90B-B8F79F6F0343Q24563657-6E341CF6-FAD6-4FE5-A7E7-98331BEE506CQ24799296-B66370BA-657E-4BD7-A3AA-0BB43841B739Q26771113-FBEC5348-2A12-4ACB-8DBC-9CEF4D728D10Q27025299-BBD1ED00-52C3-4745-8E07-0B07E89B4592Q28743556-B4BB694B-240C-490E-B99E-F86E304C2057Q29616758-04F43C14-413B-4868-9CE1-6E226409A939Q30245695-C2FC2185-0439-4108-9836-091BBA27B993Q30453032-EF163E6D-19E2-44AC-B44F-A198BA2C00F2Q30528889-31EB7B38-8EA7-4774-B55A-D4F787107E84Q30658189-0C84CA2E-A215-4C68-AFF5-CF1704B2B1A3Q30981454-0B5EF582-87A9-4F87-A214-D7CFBAD1450FQ30994297-5AB8E3B3-CBAC-40B9-8602-70AE69F11A76Q31145016-285C6B88-B06D-4264-9454-652E556535D1Q33183542-B431AA89-C565-45CC-B787-C13AE88C20BDQ33232599-4F9A6D48-E55F-42BC-A716-0A5FAA858B4FQ33753405-20FC4E94-916B-45E2-8EEB-6AE31D6F9048Q33825782-C3C95829-D3DB-49E4-9877-5DA2C0253E3FQ33910250-5E075B79-33C1-4FE1-B241-26E8263F7390Q33971521-14D71A2A-114A-4416-B7EA-B92CBB0A001EQ33981130-DA1FD97F-9606-4ED0-BFB0-D00A6AD58BD8Q34006585-F6B9A881-3244-44F1-979A-70E6205FA7ABQ34024025-4CA78FD0-7335-4B5D-9445-08C74FC99355Q34042232-974BF350-BABA-47AA-A924-94A9272B3F51Q34078706-5EF7836A-B720-4A8F-A75D-2F2597F4FB82Q34085884-4504C900-80FD-4C51-A8EA-29479C0A805DQ34142406-C5456515-1C16-4CDF-BA1D-AB0CECD8285CQ34202154-01F55631-974B-4A1C-A284-3180403C8D62Q34203994-784AA0DC-A199-4FB0-A019-B0F4B9C7A61AQ34205622-79955F76-A400-43DB-8231-B4E9D51C26EBQ34228214-E48C0115-F220-4160-A421-776C32FA28B0Q34231596-BFD05508-18C4-4F27-8EC4-7C68B616A18FQ34332272-B8D84B07-E17D-4E68-B964-6945F9713BB1Q34372192-EB034AA3-B83A-4F81-9FA1-A55D7F27655DQ34488253-085A1A12-D891-4C8A-89EF-69B885D5A682Q34489579-29AF13FC-1AFC-4193-9C75-F861CF36AD52Q34528342-CEB18EE8-32F2-476A-A831-EDE70C8B0100Q34529179-C22FADAC-5AB2-443E-A411-99A8B61B4D3DQ34574154-8548C927-700A-4F92-A720-CADBA56F5AABQ34614200-79C4F9FE-5D48-471A-A53D-3318E51E60E9
P2860
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
The epidemiology of candidemia ...... ion-based active surveillance.
@en
type
label
The epidemiology of candidemia ...... ion-based active surveillance.
@en
prefLabel
The epidemiology of candidemia ...... ion-based active surveillance.
@en
P2093
P2860
P356
P1476
The epidemiology of candidemia ...... ion-based active surveillance.
@en
P2093
Baughman WS
Perkins BA
Pfaller MA
Reingold AL
P2860
P304
P356
10.1086/313450
P407
P577
1999-11-01T00:00:00Z